FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to a formulation having nootropic activity, a pharmaceutical composition and a medicinal agent. Disclosed composition containing N-carbamoylmethyl-4-phenyl-2-pyrrolidone and at least one additional compound selected from group comprising 4-phenylpyrrolidone-2,2-(2-oxo-4-phenylpyrrolidin-1-yl)acetic acid, ethyl-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetate and optical isomers thereof.
EFFECT: claimed formulation is characterized by that it is less hygroscopic and more stable than the known substance of Fonturacetam.
13 cl, 12 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL COMPOSITIONS OF N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE FOR TREATING AND PREVENTING OBESITY | 2019 |
|
RU2732245C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE NEW COMPOSITION | 2017 |
|
RU2696277C2 |
| 4-PHENYL PYRROLIDINONE-2 DERIVATIVE, NOOTROPIC COMPOSITION THEREOF, METHOD FOR PRODUCING THEREOF AND METHOD PREVENTIVE TREATMENT OF NERVOUS SYSTEM DISORDERS | 2015 |
|
RU2611623C2 |
| DERIVATIVES OF 4-PHENYLPYRROLIDONE WITH ANTICONVULSANT AND NOOTROPIC ACTIVITY AS MEANS OF TREATING EPILEPSY AND PAROXYSMAL CONDITIONS | 2017 |
|
RU2748419C2 |
| PROCESS FOR THE PREPARATION OF 1-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE | 2017 |
|
RU2663899C1 |
| N-CARBAMOYLMETHYL-4-PHENYL-2-PYRROLIDONE POSSESSING HYPOTENSIVE ACTIVITY | 1979 |
|
SU797219A1 |
| COMPOUNDS HAVING ANTI-ISCHEMIC, ANTIANGINAL, CYTOPROTECTIVE PROPERTIES, A METHOD FOR PRODUCTION THEREOF AND USE THEREOF, A METHOD OF TREATING A NEURODEGENERATIVE DISEASE, A METHOD OF TREATING A PSYCHIC DISORDER | 2019 |
|
RU2741910C2 |
| TABLETTED PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING IT | 2013 |
|
RU2539375C1 |
| METHOD FOR LARGE-SCALE SYNTHESIS OF POTASSIUM SALT OF 2-[2-(2-OXO-4-PHENYLPYRROLIDIN-1-YL)ACETAMIDO]ETHANE SULPHONIC ACID | 2019 |
|
RU2711655C1 |
| METHOD OF PRODUCING 4-SUBSTITUTED 2-[2-OXO-1-PYRROLIDINYL] ACETAMIDE | 2016 |
|
RU2629117C1 |
